Letter to the editor concerning the pharmacological management of behavioral disturbances in patients with Alzheimer's disease

Expert Opin Pharmacother. 2020 Dec;21(18):2325-2326. doi: 10.1080/14656566.2020.1808354. Epub 2020 Aug 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Cholinesterase Inhibitors / therapeutic use
  • Humans

Substances

  • Cholinesterase Inhibitors